CREB represses p53-dependent transactivation of MDM2 through the complex formation with p53 and contributes to p53-mediated apoptosis in response to glucose deprivation

Biochemical and Biophysical Research Communications

Volumn 406, Issue 1, 2011, Pages 79-84

  Okoshi, Rintaro ^a   Kubo, Natsumi ^a   Nakashima, Kumiko ^a   Shimozato, Osamu ^a   Nakagawara, Akira ^a   Ozaki, Toshinori ^a  

^a CHIBA CANCER CENTER   (Japan)

Author keywords

Apoptosis; CREB; Glucose deprivation; MDM2; P21WAF1; P53

Indexed keywords

CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; CYCLIN DEPENDENT KINASE INHIBITOR 1; DNA BINDING PROTEIN; GLUCOSE; PROTEIN MDM2; PROTEIN P53;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; GLUCOSE DEPRIVATION; GLUCOSE METABOLISM; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; MUTATION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN INTERACTION; UPREGULATION;

APOPTOSIS; CELL LINE, TUMOR; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; DOWN-REGULATION; GLUCOSE; HUMANS; PROTEIN STRUCTURE, TERTIARY; PROTO-ONCOGENE PROTEINS C-MDM2; TRANSCRIPTIONAL ACTIVATION; TUMOR SUPPRESSOR PROTEIN P53;

EID: 79952192433     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2011.01.114     Document Type: Article

References (17)

1. Vousden K.H., Lu X. Live of let die: the cell's response to p53. Nat. Rev. Cancer 1999, 2:594-604.
2. Haupt Y., Maya R., Kazaz A., Oren M. Mdm2 promotes the rapid degradation of p53. Nature 1997, 387:296-299.
3. Kubbutat M.H., Jones S.N., Vousden K.H. Regulation of p53 stability by MDM2. Nature 1997, 387:299-303.
4. Honda R., Tanaka H., Yasuda H. Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53. FEBS Lett. 1997, 420:25-27.
5. Kulikov R., Letienne J., Kaur M., Grossman S.R., Arts J., Blattner C. Mdm2 facilitates the association of p53 with the proteasome. Proc. Natl. Acad. Sci. USA 2010, 107:10038-10043.
6. Momand J., Zambetti G.P., Olson D.C., George D., Levine A.J. The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell 1992, 69:1237-1245.
7. Pietenpol J.A., Tokino T., Thiagalingam S., El-Deiry W.S., Kinzler K.W., Vogelstein B. Sequence-specific transcriptional activation is essential for growth suppression by p53. Proc. Natl. Acad. Sci. USA 1994, 91:1998-2002.
8. Sionov R.V., Haupt Y. The cellular response to p53: the decision between life and death. Oncogene 1999, 18:6145-6157.
9. Prives C., Hall P.A. The p53 pathway. J. Pathol. 1999, 187:112-126.
10. Okoshi R., Ozaki T., Yamamoto H., Ando K., Koida N., Ono S., Koda T., Kamijo T., Nakagawara A., Kizaki H. Activation of AMP-activated protein kinase induces p53-dependent apoptotic cell death in response to energetic stress. J. Biol. Chem. 2008, 283:3979-3987.
11. Okoshi R., Ando K., Suenaga Y., Sang M., Kubo N., Kizaki H., Nakagawara A., Ozaki T. Transcriptional regulation of tumor suppressor p53 by cAMP-responsive element-binding protein/AMP-activated protein kinase complex in response to glucose deprivation. Genes Cells 2009, 14:1429-1440.
12. Ozaki T., Nakagawara A. p73, a sophisticated p53 family member in the cancer world. Cancer Sci. 2005, 96:729-737.
13. Barak Y., Juven T., Haffner R., Oren M. mdm2 expression is induced by wild type p53 activity. EMBO J. 1993, 12:461-468.
14. Stommel J.M., Wahl G.M. Accelerated MDM2 auto-degradation induced by DNA-damage kinases is required for p53 activation. EMBO J. 2004, 7:1547-1556.
15. Meulmeester E., Maurice M.M., Boutell C., Teunisse A.F., Ovaa H., Abraham T.E., Dirks R.W., Jochemsen A.G. Loss of HAUSP-mediated deubiquitination contributes to DNA damage-induced destabilization of Hdmx and Hdm2. Mol. Cell 2005, 18:565-576.
16. Watson I.R., Li B.K., Roche O., Blanch A., Ohh M., Irwin M.S. Chemotherapy induces NEDP1-mediated destabilization of MDM2. Oncogene 2010, 29:297-304.
17. Samuels-Lev Y., O'Connor D.J., Bergamaschi D., Trigiante G., Hsieh J.K., Zhong S., Campargue I., Naumovski L., Crook T., Lu X. ASPP proteins specifically stimulate the apoptotic function of p53. Mol. Cell 2001, 8:781-794.